WCN26-6246 THE CLINICAL COURSE OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS IN END-STAGE KIDNEY DISEASE AND CHANGES IN KIDNEY VOLUME DURING THE DIALYSIS PHASE

Read full text Summarise with VIRAT
Authors: Kazushige Hanaoka, Yudo Tanno, Takashi Udagawa, Maiko Furuya, Nanae Matsuo, Yukio Maruyama, Ichiro Ohkido, Takashi Yokoo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the fourth leading cause of progressive kidney disease leading to end-stage kidney disease (ESKD) in Japan. Total kidney volume (TKV) serves as a surrogate marker for disease severity until patients reach ESKD. While numerous clinical studies have focused on the pre-ESKD phase, research on clinical outcomes and kidney volume changes after ESKD remains limited.

Fields of Study & Subjects

Genetic and Kidney Cyst Diseases Chronic Kidney Disease and Diabetes Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105755–105755
Publication date
25 March 2026
Language
EN